insulin Glargine-yfgn

CHEBI:CHEBI_749536

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

brand_name
SEMGLEE
brand_name_base
SEMGLEE
rxcui
2563977
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
marketing_start_date
20211116
package_marketing_start_date
20211116
route
SUBCUTANEOUS
marketing_category
BLA
active_ingredient_strength
100 [iU]/mL
nui
M0011417
pharm_class_epc
Insulin Analog [EPC]
pharm_class
Insulin [CS]
pharm_class_cs
Insulin [CS]
labeler_name
Mylan Specialty L.P.
manufacturer_name
Mylan Specialty L.P.
active_ingredient_name
INSULIN GLARGINE
unii
2ZM8CX04RZ
generic_name
insulin glargine-yfgn
product_ndc
83257-015
application_number
BLA761201
spl_id
4ad0964c-21f9-4fd0-a8ed-c0202d1b4fce
package_ndc
83257-015-32
package_description
5 SYRINGE in 1 CARTON (83257-015-32) / 3 mL in 1 SYRINGE
spl_set_id
f8cf3733-952d-4cf1-99ff-5ec7b7247f75
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class